Downloads provided by UsageCounts
pmid: 32835190
pmc: PMC7402276
handle: 10668/3260 , 10261/217969 , 20.500.12010/11856 , 11571/1372200
pmid: 32835190
pmc: PMC7402276
handle: 10668/3260 , 10261/217969 , 20.500.12010/11856 , 11571/1372200
During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and ESCMID published a position paper to provide guidance for physicians involved in the care of patients with chronic liver disease. While some healthcare systems are returning to a more normal routine, many countries and healthcare systems have been, or still are, overwhelmed by the pandemic, which is significantly impacting on the care of these patients. In addition, many studies have been published focusing on how COVID-19 may affect the liver and how pre-existing liver diseases might influence the clinical course of COVID-19. While many aspects remain poorly understood, it has become increasingly evident that pre-existing liver diseases and liver injury during the disease course must be kept in mind when caring for patients with COVID-19. This review should serve as an update on the previous position paper, summarising the evidence for liver disease involvement during COVID-19 and providing recommendations on how to return to routine care wherever possible.
upper limit of normal, Upper limit of normal, ALT, Hepatocellular carcinoma, Metabolic-dysfunction associated fatty liver disease, ACE2, Medical Subject Headings::Diseases::Neoplasms, RC799-869, ULN, Review, Esophagogastroduodenoscopy, LT, ACLF, ACE-I, Severe acute respiratory syndrome coronavirus 2, model for end-stage liver disease, HCC, Non-alcoholic steatohepatitis, Cancer, Model for end-stage liver disease, Coronavirus disease 2019, NASH, ERC, hepatocellular carcinoma, Diseases of the digestive system. Gastroenterology, Angiotensin-converting enzyme 2, Nucleoside analogue, Telemedicine, Acute-on-chronic liver failure, Liver, Cirrhosis, acute-on-chronic liver failure, Medical Subject Headings::Diseases::Digestive System Diseases::Liver Diseases::Liver Cirrhosis, Medical Subject Headings::Information Science::Information Science::Communications Media::Telecommunications::Telemedicine, severe acute respiratory syndrome coronavirus 2, Endoscopic retrograde cholangiography, 610, MAFLD, Aspartate aminotransferase, Medical Subject Headings::Anatomy::Digestive System::Liver, coronavirus disease 2019, Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Síndrome respiratorio agudo grave, angiotensin-converting enzyme 2, NAFLD, NUC, AST, EGD, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Digestive System Surgical Procedures::Liver Transplantation, IL-6, Transplantation, Cirrhosi, SARS-CoV-2, interleukin-6, OGD, non-alcoholic fatty liver disease, COVID-19, endoscopic retrograde cholangiography, MELD, Coronavirus, liver transplant, oesophagogastroduodenoscopy, Angiotensin-converting enzyme inhibitor, Alanine aminotransferase, non-alcoholic steatohepatiti
upper limit of normal, Upper limit of normal, ALT, Hepatocellular carcinoma, Metabolic-dysfunction associated fatty liver disease, ACE2, Medical Subject Headings::Diseases::Neoplasms, RC799-869, ULN, Review, Esophagogastroduodenoscopy, LT, ACLF, ACE-I, Severe acute respiratory syndrome coronavirus 2, model for end-stage liver disease, HCC, Non-alcoholic steatohepatitis, Cancer, Model for end-stage liver disease, Coronavirus disease 2019, NASH, ERC, hepatocellular carcinoma, Diseases of the digestive system. Gastroenterology, Angiotensin-converting enzyme 2, Nucleoside analogue, Telemedicine, Acute-on-chronic liver failure, Liver, Cirrhosis, acute-on-chronic liver failure, Medical Subject Headings::Diseases::Digestive System Diseases::Liver Diseases::Liver Cirrhosis, Medical Subject Headings::Information Science::Information Science::Communications Media::Telecommunications::Telemedicine, severe acute respiratory syndrome coronavirus 2, Endoscopic retrograde cholangiography, 610, MAFLD, Aspartate aminotransferase, Medical Subject Headings::Anatomy::Digestive System::Liver, coronavirus disease 2019, Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Síndrome respiratorio agudo grave, angiotensin-converting enzyme 2, NAFLD, NUC, AST, EGD, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Digestive System Surgical Procedures::Liver Transplantation, IL-6, Transplantation, Cirrhosi, SARS-CoV-2, interleukin-6, OGD, non-alcoholic fatty liver disease, COVID-19, endoscopic retrograde cholangiography, MELD, Coronavirus, liver transplant, oesophagogastroduodenoscopy, Angiotensin-converting enzyme inhibitor, Alanine aminotransferase, non-alcoholic steatohepatiti
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 130 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.1% |
| views | 37 | |
| downloads | 65 |

Views provided by UsageCounts
Downloads provided by UsageCounts